The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

The Bristol Myers Squibb medicine is said relieve symptoms without causing some of the harsh side effects of drugs already in use. Meanwhile, thousands of patients allege in a lawsuit that drugs used ...

Bristol-Myers Squibb won Food and Drug Administration approval late Thursday for its novel schizophrenia drug, Cobenfy. BMY ...

As of now, Bristol Myers Squibb has registered a Year-to-Date (YTD) stock performance of +1.48%. This figure starkly contrasts with the S&P 500’s impressive YTD performance of +20.45%. While BMY’s ...

University of Bristol has been crowned ‘AI University of The Year’ at the National AI Awards solidifying the University’s reputation as a leader in artificial intelligence research and education. But ...

Mark Robins has revealed that dipping into the free agent transfer market is not an option for him at Coventry City at this ... club after being released by Bristol City in the summer.

A Collier County jury has convicted a Fort Myers man of second-degree murder for a March 2021 deadly shooting at a North Naples restaurant. Jason Ortiz, 33, was charged in the March 12 ...

BRISTOL, Conn. (WTNH) — A parent of a Bristol student was arrested on Wednesday after making a concerning post on social media. Bristol police investigating shots fired at park David Arroyo, Jr ...

The funding aims at supporting further advancements on the Coventry-based firms technology platform to accelerate the development of biologic therapeutics. Funding was co-led by BGF, Octopus ...

Bristol Myers Squibb (BMY) ended the recent trading session at $48.59, demonstrating a -1.4% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily ...

Shares of Bristol Myers Squibb Co. BMY slipped 1.40% to $48.59 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.07% ...